What is CellCentric worth?
$382.5Mlast known valuation
CellCentric last raised $116.5M in its Later Stage VC (Series C) (Apr 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for CellCentric
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Later Stage VC (Series C) | $116.5M | ▮ | ▮ |
| Jul 2024 | Later Stage VC (Series B) | $35.5M | ▮ | ▮ |
How CellCentric's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CellCentric, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is CellCentric worth?
- CellCentric's implied valuation is $382.5M, based on the PA Mark composite price of about $5 per share as of Sep 2026.
- How much has CellCentric raised?
- CellCentric has raised $280.5M in total funding across 2 recorded rounds.
- When did CellCentric last raise?
- CellCentric last raised in Apr 2025 (Later Stage VC (Series C)), raising $116.5M.